Myomo
About
About Myomo
Myomo develops powered upper-limb orthoses for people with arm and hand weakness caused by stroke, brachial plexus injury, cerebral palsy and other neuromuscular conditions. The wearable MyoPro brace senses faint electrical activity in the user's muscles and assists the intended movement of the elbow, wrist or hand.
Different configurations support reaching, lifting, grasping and releasing during daily activities and rehabilitation. A clinical and fitting network assesses candidates, customises each device and trains the wearer, while reimbursement teams work with insurers and public programmes. Myomo manufactures MyoPro as a prescribed medical device and provides continuing patient support.
Financials
- MYO - NYSE American - USD
Team
- Paul R. Gudonis - Chairman and Chief Executive Officer - This role identifies Paul R. Gudonis as part of Myomo's leadership or founding team.
Timeline
Events
- 2026-08-05 - Market Signal - Myomo raises 2026 guidance as MyoPro adoption expands
Second-quarter revenue increased 21% year over year to $11.7 million. Referral-network sources through MyoConnect and other channels generated 53% of quarterly revenue. Myomo raised full-year revenue guidance to $45 million–$47 million while continuing to expand clinical awareness and referrals for MyoPro.
Source - 2025-04-30 - Product Launch - Myomo launches MyoPro 2x wearable robotics brace
MyoPro 2x focuses on improved donning, fit and function for user independence. The launch expands Myomo’s flagship wearable medical robotics product line after Medicare reimbursement progress. The device targets arm and hand function support for patients with upper-limb impairment.
Source - 2024-04-29 - Regulatory - Myomo receives Medicare benefit category determination for MyoPro
Myomo received a final Medicare benefit category determination for the MyoPro powered arm brace. The decision supported reimbursement pathways for a wearable robotic orthosis used by people with upper-limb impairment. The milestone matters because reimbursement and clinical access drive adoption for assistive robotics.
Source
Context
Comparable profiles
- Chengtian Technology (程天科技)
comparable profile - Medical Exoskeletons · Rehab Exoskeleton Builder
- Wearable Robotics
comparable profile - Medical Exoskeletons · Rehab Exoskeleton Builder
- Wandercraft
comparable profile - Medical Exoskeletons · Rehab Exoskeleton Builder
- Ottobock
comparable profile - Medical Exoskeletons · Rehab Exoskeleton Builder
Context tags
- Medical exoskeletons - Peer Group
- Rehab exoskeleton builder - Peer Group
- Intent-based motion control - Capability